A Phase II Study of XELOX and Cetuximab as First-Line Therapy in Patients With KRAS Wild Type Metastatic Colorectal Cancer (FLEET2 Study)
2016 ◽
Vol 15
(4)
◽
pp. 329-336
◽
Keyword(s):
Phase Ii
◽
2001 ◽
Vol 37
◽
pp. S272
◽